Systemic mastocytosis (Q39209): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Canary Token | |||
dki-india-2A21.0 | |||
| Property / Canary Token: dki-india-2A21.0 / rank | |||
Normal rank | |||
Revision as of 04:33, 13 August 2026
Systemic mastocytosis (SM) comprises a heterogeneous group of rare acquired and chronic haematological malignancies that are related to an abnormal proliferation of mast cells in tissue, including bone marrow, with or without skin involvement. SM can be divided into indolent SM (ISM) and aggressive SM (ASM).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A21.0 |
||
| English | Systemic mastocytosis |
Systemic mastocytosis (SM) comprises a heterogeneous group of rare acquired and chronic haematological malignancies that are related to an abnormal proliferation of mast cells in tissue, including bone marrow, with or without skin involvement. SM can be divided into indolent SM (ISM) and aggressive SM (ASM). |
Statements
CID11:2A21.0
0 references
dki-india-2A21.0
0 references
